Digital Therapeutics and Their Impact on Healthcare

Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new way of treatment in which digital systems are used as regulatory‐approved, to treat medical conditions as prescribed therapeutic interventions. There is a growing number of DTx developed on the market today as well as pipeline products in development following internationally-recognized, quality, design and manufacturing standards. DTx will provide a new approach to treatment and disease management in which patients have the possibility to learn more about their conditions and treatment options and this will lead to manage their own health and disease conditions.

 

This report provides an overview of current marketed and pipeline DTx products within the 8MM (France, Germany, Italy, Spain, UK, US, Japan, China).

 

Scope

GlobalData’s Digital Therapeutics and Their Impact on Healthcare report combines primary research from a cross-specialty panel of experts with in-house analyst expertise to provide an assessment of the development landscape.

 

Components of the slide deck include primary and secondary research:

 

Quotes from 10 key opinion leaders (7 US, 1 EU, 2 Japan) and 2 payers (1 US and 1 UK)

Summary of DTx product definitions and classifications

Overview of key DTx marketed products and key pipeline DTx products

Trends in DTx market

Call-outs of key information and details

Insight from GlobalData’s specialist healthcare analysts

Reasons to buy

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

 

Develop business strategies by understanding the trends shaping and driving the global DTx market.

 

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global DTx market in the future.

 

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

 

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

 

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

 

Companies mentioned

WellDoc

 

Voluntis

 

Big Health

 

Pear Therapeutics

 

Kaia Health

 

Propeller

 

Teva

 

My mhealth

 

Omada Health

 

Happify Health

 

Atentiv

 

2Morrow

 

NaturalCycles

 

Samsung

 

Roche

 

AstraZeneca

 

Boehringer Ingelheim

 

Sanofi ...